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Abstract 
Background and Purpose 
Depression in older adults is a significant problem that often goes undetected and untreated in 
primary care.  The U.S. Preventive Services Task Force recommends screening adults for 
depression in primary care to increase detection, so it can be adequately managed.  Despite this 
recommendation, screening rates in primary care are low.  The purpose of this project was to 
implement a screening intervention and examine the effect of screening on the treatment of 
depression in older adults. 
Methods 
The screening intervention was implemented as an evidence-based project in a small primary 
care practice. Consenting adults ≥ 65 years of age were screened with the Patient Health 
Questionnaire-9 (PHQ-9).  Research indicates the PHQ-9 is valid and reliable for older adults.  A 
post-screening chart audit was conducted to collect data and analyze the outcome of screening 
related to treatment. 
Conclusions 
A total of 38 participants were screened.  Five (13.2%) participants had a positive screening, two 
received treatment during the follow up period.  The number of participants who were treated 
after a positive screening was significant (p= .040). 
Implications for Practice 
Screening can increase detection and treatment of depression and reduce the associated illness 
burden in the older adult population. 
 
 Keywords: depression screening, older adults, treatment, primary care  
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Screening older adults for depression in primary care 
Since the turn of the century, depression has garnered considerable attention in health 
care.  Recognition of the negative impact depression has on individuals and the health system 
prompted researchers and experts to explore strategies for mitigating the problem.  These efforts, 
and research highlighting the prevalence of unrecognized depression among adults managed by 
general practitioners, led to a focus on depression in the primary care setting. 
Problem Statement 
Depression is a well-known problem among older adults in the primary care.  Despite 
awareness of this problem, a significant portion of this population remains undiagnosed.  In the 
United States, approximately 7 million adults over age 65 are affected by depression (Centers for 
Disease Control, 2012).  Per the Centers for Medicare and Medicaid Services (CMS) (2011), up 
to 25% of older adults with comorbid medical conditions experience depression.  Meanwhile, an 
estimated 15.1% of Arizona seniors have depression (United Health Foundation, 2016).   
Research indicates Primary Care Providers (PCP) detect 40% to 50% of depression cases 
among older adults (Park & Unutzer, 2011).  Failure to recognize depression in primary care is 
significant because older adults tend to receive treatment in this setting.  Up to two-thirds of 
older adults treated for depression receive the treatment from their primary care provider 
(O’Conner, Whitlock, Beil & Gaynes, 2009).  Thus, failure to detect is a significant barrier to 
treatment. 
 Undiagnosed and untreated depression associates with significant individual and societal 
burden.  Personal consequences of depression include suffering, diminished quality of life, and 
increased risk of suicide (American Medical Association, 2015).   The suicide rate among 
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Arizona residents over 65 was 22.7 per 100,000 residents in 2016 compared to 16 per 100,000 
for this age group in the greater U.S. (United Health Foundation, 2016).   
Societal implications of depression originate from the burden imposed on the greater 
health system.  Elderly patients with depression and co-morbid chronic conditions have 
significantly higher health care costs compared to those without depression due to increased 
utilization including frequent hospitalization, emergency department visits, and doctor visits 
(Centers for Disease Control, 2012).  Depression also complicates the treatment and outcome of 
co-morbid medical conditions.  The Centers for Disease Control (CDC) estimates the economic 
cost of depression from lost productivity, health expenditures, and suicide exceeded 200 billion 
dollars in 2010 (CDC, 2016). 
  In the last several years, awareness of the depression burden led to a shift in public 
health policy toward a focus on recognizing depression in primary care.  In 2002, the U.S. 
Preventive Service Task Force (USPSTF) recommended depression screening for adults in 
primary care (USPSTF, 2002).  The USPSTF recommendation influenced the 2011 Medicare 
decision to pay for annual depression screenings in primary care (CMS, 2011).  Clinical practice 
guidelines from the Agency for Healthcare Research and Quality (AHRQ) recommend routine 
depression screening for all adults in primary care (AHRQ, 2016). 
Purpose 
            As the major entry point for health care services, primary care providers (PCP) are in a 
unique position to detect and treat depression in the older adult population.  The purpose of this 
paper is to discuss the background and significance of the problem, the strategy used to search 
the literature, synthesize the evidence, and discuss an evidence-based project that implemented 
the evidence into practice.  
SCREENING OLDER ADULTS           5 
Background and Significance 
Screening older adults with a standardized age-appropriate instrument can help 
PCPs detect depression in this population.  In a systematic review, Watson and Pignone 
(2003) examined the accuracy of depression screening instruments in the older adult 
primary care population and identified several instruments with good sensitivity and 
specificity including the Geriatric Depression Scale (GDS), Center for Epidemiological 
Studies Depression Scale, and the SelfCARE(D).  This review influenced the original 
USPSTF recommendation.   
O’Conner, Whitlock, Beil, and Gaynes (2009) expanded upon this research by 
conducting a systematic review to aid the USPSTF in updating its original 2002 
screening recommendation.  The authors concluded screening helps identify depression 
but screening alone does not improve outcomes (O’Conner, Whitlock, Beil & Gaynes, 
2009).  Instead, screening as part of a greater approach that includes additional support 
and treatment is beneficial (O’Conner, Whitlock, Beil & Gaynes, 2009).  These findings 
influenced the revised USPSTF recommendations in 2009.   
In a recent systematic review, O’Conner et al. (2016) examined evidence 
regarding benefits and harms of depression screening in the adult population to provide a 
comprehensive updated review for the USPSTF.  The rationale for routine screening is to 
identify undiagnosed depression and reduce the amount of time between depression 
onset, and initiation of treatment (O’Conner et al., 2016).  The authors concluded 
depression screening programs increase the likelihood of remission or reduction of 
depression symptoms in response to treatment (O’Conner et al., 2016).    
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An increase in diagnosis and treatment from screening is significant considering the 
prolonged time it typically takes people to receive treatment after onset of symptoms.  According 
to Pence, O’Donnell, and Gaynes (2012), the median time from symptom onset to depression 
treatment is eight years.  Meanwhile, O’Conner et al (2016) report the average onset to treatment 
time is four years.   
Evidence also indicates screening and subsequent treatment of depression can reduce 
suicide.  A systematic review of suicide prevention programs reveals depression screening and 
awareness programs correlate with reduced risk of suicide in older adults (Lapierre et al., 2011).  
Furthermore, screening and treatment interventions can reduce non-suicide related mortality.  
Gallo et al. (2013) found that older adults who were screened, and received depression treatment 
interventions, had a lower mortality risk compared to those receiving usual care; mortality risk 
among those in the depression treatment group was similar to people without depression.  
According to the USPSTF (2015), both medication and psychotherapy can increase rates of 
remission from depression.    
A common theme in the literature regarding depression screening is the relation between 
screening and treatment.  Specifically, the goal of screening in primary care is to detect 
depression so it can be treated.  Depression is treatable in up to 80% of cases (CDC, 2012). 
Despite evidence supporting depression screening in primary care, expert 
recommendation, and initiatives from public health authorities, it appears screening is not yet 
standard practice.  Data from the National Ambulatory Medical Care Survey from 2005 to 2010 
reveals an average annual screening rate of 1.8% in primary care (McGoey, Huang & Palmes, 
2013).  Meanwhile, Maimone and Mahartta (2015) analyzed a random sample of 500 patients 
and identified a slightly higher screening rate of 14.6% (Maimone and Mahartta, 2015).   While 
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estimates of screening rates may vary, the low rates indicate screening practices are 
under-utilized in primary care.   
The results of this inquiry, indicating screening helps detect depression and can 
result in subsequent treatment, leads to the following clinically relevant PICOT question: 
“In older adult primary care patients, how does depression screening, compared to no 
screening, affect treatment over a three-month period?” 
Search Strategy 
An extensive search of research databases was conducted to identify evidence 
pertinent to the clinical question.  This entailed an exhaustive search of three databases: 
PsycINFO, PubMED, and CINAHL.  Each database search entailed use of keywords and 
Boolean connectors.  The keywords used are depression screening, older adults or 
elderly, primary care or general practice, and treatment or referral.  Title and abstracts 
of results from each database were reviewed and relevant articles saved for further 
appraisal.  A total of 28 articles were identified from the search.  Each study was 
critically appraised according to the inclusion and exclusion criteria.  Ten final studies 
relevant to the clinical question were included in an evaluation table (Appendix A).   
Critical Appraisal and Synthesis of Evidence 
Studies contained in this review are generally high quality studies with varying 
levels of evidence.  Six studies represent level III evidence or higher, and the remainder 
are level IV evidence.  All studies are quantitative and include depression screening as a 
component, either alone, or as an integral part of a broader intervention.  There is 
significant heterogeneity among interventions across studies ranging from screening only, 
to screening with feedback, and intensive support.  Outcome variables for the level I 
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through III studies include depression response or symptom reduction, remission, and mortality.  
Meanwhile, lower level studies examined screening rates and correlations between screening, 
diagnosis, treatment, and outcomes.   
Overall, the studies reported an adequate amount of demographic data, employed 
appropriate methods, and had a clearly-defined research purpose.  All but three studies had a 
greater number of female than male participants.  Four studies focused exclusively on older 
adults while the remainder contained the general adult population including older adults.    
Evidence from the six level I through III studies reveal varying degrees of support for 
depression screening.  The effect of screening is weakest when used alone and gets stronger 
when combined with additional support including treatment.  This finding was consistent for 
outcome variables across all the higher-level studies.  Five of the six studies report screening 
interventions improved depression symptoms, four report increased rates of remission, in three 
there was a reduction in suicidal ideation, and two report a reduction in depression related 
mortality risk.  Studies included in the systematic reviews were well designed RCT’s and cohort 
studies with adequate follow-up time, randomization, blinding and concealment, acceptable 
attrition rates, and homogenous sample characteristics.  However, some studies included in the 
systematic reviews were underpowered with wide confidence intervals and failed to find even 
large improvements in depressive symptoms significant.  In contrast, findings from adequately-
powered studies were significant and more precise with narrow confidence intervals.   
Results from the level IV studies were consistent for similar outcomes.  Screening rates 
were low across all studies.  Three studies showed higher rates of diagnosis from screening and 
in two of these studies, screening was associated with initiating treatment. These studies were 
retrospective, had large sample sizes, utilized data from electronic health records, and employed 
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appropriate measures including regression and variable analysis to limit confounding 
factors and bias.  The PHQ-9 and HAM-d were the most commonly used screening 
instruments across studies.   
Conclusion from the Evidence 
Screening older adults for depression in primary care increases detection of the 
illness and can lead to diagnosis and subsequent treatment.  When screening results in 
diagnosis and treatment, it improves outcomes by reducing symptoms, increasing rates of 
remission, and lowering the risk of depression related mortality.   
Project Aims 
The purpose of this evidence-based project is twofold: implement the USPSTF 
screening recommendation to screen older adults for depression in primary care and 
examine the effect of screening on treatment. 
EBP Model for Guiding Project 
The Stetler Model of Evidence-Based Practice provides a guide for implementing 
the depression screening intervention.  The model consists of distinct phases that guide a 
change in practice: identifying a need for change, assessing the evidence, making 
decisions about the evidence, incorporating the evidence into a plan for use and 
implementing the plan, and evaluating whether the goals related to implementation were 
met (Melnyk & Fineout-Overholt, 2015).  The model can be used to implement change 
by an individual, group, or entire organization (Stetler, 2001).  The flexibility of the 
Stetler Model makes it a good fit for implementing a depression screening in a small 
primary care practice. 
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Methods 
Human Subjects Protection 
Approval for this project was granted by the Arizona State University Institutional 
Review Board and the project site.  Participation in the project was voluntary and no personally 
identifying data was collected. 
Setting and Participants 
The project was implemented at a small urban primary care practice in Arizona.  Patients 
were eligible to participate if they were ≥ 65 years of age, English speaking, able to give consent, 
and had an appointment on the day of screening.  Patients under age 65, unable to give consent, 
and non-English speaking were excluded.  
Design and Procedures 
The project contained two phases: a depression screening intervention and a follow up 
chart audit.  During the screening phase, eligible patients were given a cover letter explaining the 
purpose of the project and time was taken to answer questions.  Consenting patients were 
screened with the PHQ-9 and results communicated to both the patient and the PCP.  The PCP 
documented the screening result in the electronic medical record (EMR). 
Three months after the screening intervention, in February 2018, the chart audit was 
completed.  To facilitate the audit, the EMR was utilized to query all patients who had an 
appointment on the dates of screening.  A documented screening result from the date of 
screening connected the patient to the project.   
Measures 
The PHQ-9 was derived from the Primary Care Evaluation of Mental Disorders Patient 
Health Questionnaire and designed for use in primary care settings (Kroenke, Spitzer & 
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Williams, 2001).  Items on the PHQ-9 are based on the diagnostic criteria for depression 
from the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV); it can be used 
as an initial screening tool and to assess the ongoing severity of depression (Kroenke, 
Spitzer & Williams, 2001). The instrument demonstrates validity and reliability when 
used on older adults with a sensitivity of 88% and specificity of 80% (Phelan et al, 2010).  
A score ≥10 is considered a positive screening (Kroenke, Spitzer & Williams, 2001).  
Thus, for project purposes, this was the score used to determine a positive screening. 
Data Collection and Analysis 
Data collection occurred during the chart audit.  Relevant data was transferred 
onto a data collection spreadsheet in de-identified form to protect the privacy of 
participants.  Specific data included demographic information such as age and gender, 
screening result, diagnosis status before and after screening, and treatment status before 
and after screening.   
Descriptive statistics were used to describe the sample and outcome variables.  A 
two-tailed test was used to analyze the data and the critical value set at p<.05.    For 
evaluation purposes, treatment was defined as either initiating a new treatment or 
changing an existing treatment after the screening.   SPSS was used to store and manage 
the data (cite SPSS). 
Results 
The sample (N=38) consisted of 23 females (60.5%) and 15 males (39.5%) 
participants.  Mean age was 79.7 (SD=7.8), the minimum age was 66 and maximum age 
in the 90 range.  The maximum score on the PHQ-9 was 16 with a mean score of 3.4 
(SD=4.4) among all participants.  Five participants (13.2%) screened positive for 
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depression and 32 (86.8%) were negative.  Twelve (31.6%) participants had an existing 
diagnosis of depression.  One participant was lost to follow up because there was no documented 
screening result, and thus, no way to connect the participant to the project. 
Of the five who screened positive, two received treatment after the screening.  Due to the 
small sample size, Fisher’s exact test was used to test the data for statistical significance.  At an 
alpha of 0.05, the proportion of participants who received treatment after screening is significant 
(p=.040).   Participants were more likely to get treatment after a positive screening (OR= 21.3, 
95% CI [1.47-310]).   
Discussion 
The purpose of this project was to implement an evidence-based depression screening 
and examine how screening effects treatment.  Results of the analysis indicate there was a small, 
but statistically significant, increase in treatment after the screening intervention. This finding 
indicates screening can be an effective way to increase diagnosis and treatment of depression in 
older adults. 
Several themes emerged from the data analysis.  First, the prevalence of depression 
among participants is similar to the greater population.  An estimated 15% of Arizona seniors 
suffer from depression (United Health Foundation, 2016).  In comparison, 13.8% of participants 
screened positive for depression.  Next, there was a greater number of female than male 
participants.  This is a phenomenon found in most of the studies reviewed from the literature.   
Another theme to emerge from the data is that screening serves multiple purposes in the 
management of depression.  Kroenke (2012) reports the PHQ-9 is a multipurpose instrument 
ideal for screening for undetected depression, gauging the severity of depression, and monitoring 
the effectiveness of treatment.  This concept is evident when examining the screening results.  
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Four of the 5 participants with a positive screening had existing diagnosis and treatment.  
For these individuals, screening positive suggested their treatment was not effective.  
Meanwhile, 8 participants with a negative screening had an existing diagnosis and 
treatment.  Some of these participants scored zero on the PHQ-9 which indicates 
remission of symptoms.  In these cases, the negative screening reflects adequate 
treatment. 
Implications 
The findings of this project support the use of screening in primary care to detect 
depression and increase the number of older adults who receive treatment.  These 
findings add to the existing body of evidence supporting the USPSTF screening 
recommendation. Providers can screen patients with an age appropriate instrument like 
the PHQ-9 to detect depression, gauge the severity of known depression, and evaluate the 
effectiveness of treatment. 
It is important to note that this study was conducted over a short period of time 
and focused solely on the relationship between screening and treatment.  As a result, it 
was not possible to evaluate the adequacy of treatment and follow up.  This is important 
because there is evidence that depression is often inadequately treated in primary care.  
According to Park and Unutzer (2011), most older adults treated for depression receive 
the treatment from their PCP but only around 20% are adequately treated.  Consequently, 
future studies should examine the adequacy of treatment over time. In addition, larger 
studies are needed to better estimate the effect of screening. 
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Limitations 
A major limitation of this study is the small sample size. This makes the estimated effect 
of screening less precise and is evident in the wide confidence interval. A small sample size also 
makes the findings less generalizable to the greater population.   Therefore, the results should be 
interpreted within the context of these limitations.   
Conclusion 
Despite the limitations of this project, the results suggest screening has an important role 
in addressing depression.  Screening older adults for depression can increase detection of the 
illness and lead to diagnosis and treatment.  Adequate treatment can reduce the burden 
depression imposes on individuals by improving quality of life and minimizing its adverse effect 
on co-morbid medical conditions.  In addition, a higher number of older adults treated for 
depression may reduce the impact on society associated with increased health costs from higher 
utilization of health services. 
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Table 1 
Evaluation Table 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Akincigil & 
Matthews (2017).   
National rates and 
patterns of 
depression 
screening in 
primary care: 
Results from 2012 
and 2013. 
 
 
Funded by AHRQ 
 
No conflicts of 
interest or bias 
noted 
 
USA 
Inferred- 
Diffusions of 
Innovations 
Framework 
Cross-sectional 
secondary 
analysis  
 
Purpose: 
examine rates 
and patterns of 
DS among PCP 
visits and identify 
associations with 
initiatives such as 
EHR adoption 
through 
meaningful use 
or quality 
initiatives. 
n= 33,653 patient-
physician 
encounters 
F>M 
 
IC: 
Adults without 
existing 
depression; PC 
visit 
 
EC: 
Under age 18; 
prior depression 
dx  
 
 
IV1- gender 
IV2- EHR use 
IV3-participation 
meaningful use or 
federal value 
program 
IV4- quality 
reimbursement 
 
DV-DS 
NR Stata statistical 
software, 
Pearson Chi-
square tests and 
Multi-variate 
logistic regression 
CI=95% 
DS rate= 4.2% 
47% of screened 
got new dx of 
MDD 
 
EHR use- 5% DS 
(AOR 1.81, p= 
.001) 
 
Gender- 
M: 3.8% 
: 4.4% (AOR 
1.36, p= .110) 
 
Quality 
reimbursement- 
NS (AOR 1.09, 
p=.087) 
Level IV 
 
Strengths: 
Large sample 
size, general 
description of 
screening 
practices, 
appropriate 
methods 
 
Weaknesses: 
Assumed 
screening 
occurred if new 
dx of MDD, 
retrospective 
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Conclusion: 
Explanatory 
significance; 
screening rates 
are low.  Quality 
reimbursement 
not a predictor of 
screening 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Gallo et al. (2013) 
 
Funding: NIMH 
 
Bias/Conflicts: 
none 
 
USA 
Inferred-Health 
Prevention 
framework 
RCT-long-term 
f/u of 
PROSPECT 
study / 
quantitative 
 
Purpose:  
Assess whether 
the increased 
mortality risk 
among patients 
with MDD can 
be reduced to the 
risk of those 
without MDD 
n= 1226 
 
Setting: 20 PC 
practices in 3 
cities 
 
Age stratified RS 
 
IC:  age ≥ 60; 
MMSE score >17; 
English speaking; 
CES-D score > 20 
IV1-MDD in IG 
IV2-No MDD in 
IG 
IV3-MDD in CG 
DV-mortality risk 
(risk of death of 
patients with 
MDD in IG vs 
risk in those with 
MDD in CG) 
CES-D  
HAM-D  
 
CES-D tested in 
older adults: 
sensitivity 83%, 
specificity 78% 
 
Unknown if 
HAM-D tested in 
older adults 
SAS 9.1 and Stata 
12.0 Cox 
proportional 
hazards 
regression; 
Kaplan & Meier 
method 
 
CI= 95% 
Hazard ratio for 
MDD in CG 1.90 
(95% CI: 1.57-
2.31) 
 
Hazard ratio for 
MDD in IG 1.09 
(95% CI: 0.83-
1.44) 
 
Hazard ratio for 
MDD in IG 
compared to 
MDD in CG 0.76 
(95% CI: 0.57-
1.00) 
Level II 
 
Strengths: 
Large sample 
size, long f/u 
period, RCT 
 
Weaknesses: 
Interventions used 
in IG may not be 
feasible or cost 
effective in 
general settings 
 
Conclusions: 
Findings indicate 
treating MDD in 
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older adults 
reduces risk of 
mortality/morbidit
y.  Aligns with 
other studies that 
treating MDD has 
substantial 
benefits.   
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Burton (2012).  
Diagnosis and 
treatment of 
depression 
following routine 
screening in 
patients with 
coronary heart 
disease or 
diabetes: a 
database cohort 
study. 
 
Funding:  
National Health 
Service of 
Scotland 
Quality and 
Outcomes 
Framework 
RCS / 
quantitative 
 
Purpose:  
Evaluated patient 
records to 
examine relation 
between DS and 
dx/tx in the 
month following 
DS in patients 
with chronic 
illness  
n=67,358 
Data from General 
Practice 
Administration 
System in UK 
F>M 
 
 
Setting:  
237 PC practices 
 
IC: 
Dx of coronary 
heart disease or 
diabetes and DS 
during study 
period 
IV-DS 
 
DV1- dx within 4 
weeks 
DV2-tx within 4 
weeks 
PHQ-9 
 
PHQ-9 tested in 
older adults: 
sensitivity 88%, 
specificity 80% 
Self-control, case-
series method 
 
Relative 
incidence  
 
95% CI 
DV1: 
RI 3.03 (95% CI, 
2.44-3.78) 
 
DV2: 
RI 1.78 (95% CI, 
1.54-2.05) 
Level IV 
 
Strengths: 
Large sample 
size, case-control 
design reduces 
confounding 
factors related to 
differences 
between subjects 
 
Weaknesses: 
Lower level of 
evidence, 
retrospective 
study, did not 
include those with 
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Bias/ Conflicts of 
interest: none 
identified 
 
United Kingdom 
 
EC: 
DS, dx, and tx on 
same day 
DS, dx, and tx on 
same day 
 
Conclusions: 
Findings indicate 
there was higher 
rate of dx and tx 
after screening.  
Screening is 
effective in 
people with 
chronic illness 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Lapierre et al. 
(2011).  
Systematic review 
of elderly suicide 
prevention 
programs. 
 
Funding: not 
disclosed 
 
Bias/Conflicts: 
none noted 
 
Inferred -Health 
Prevention 
Framework 
SR / quantitative 
 
Purpose: 
examine results 
of interventions 
for suicidal 
elderly persons to 
identify 
successful 
strategies 
 
Method: 
Searched 5 
N=19 studies 
n= 31,505 
 
Setting: 
Multi-national 
 
IC: 
Studies with 
empirical 
evaluation of a 
suicide 
intervention or 
prevention 
IV1- DS 
IV2- tx 
IV3- education 
interventions 
IV3- social 
isolation 
reduction 
DV1-suicidal 
ideation 
DV2-depression 
symptoms 
Specific 
instruments NR 
Qualitative 
synthesis 
DV1: 
3/4 studies 
showed 
significant 
reduction in SI (p 
< 0.05) 
1 study showed 
NS reduction in 
SI 
 
DV2: 
3/4 studies 
showed 
Level I 
 
Strengths: 
 
Large sample 
size, SR, focus on 
elderly 
 
Weaknesses: 
 
No MA due to 
heterogeneity of 
interventions in 
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Country: 
International 
network of 
researchers 
databases from 
1966-2009 
program; age ≥60; 
peer reviewed 
significant 
reduction in 
symptoms; 
1 study showed 
no difference 
between IG and 
CG 
studies, some 
interventions may 
not be feasible  
 
Conclusion: 
 
Findings indicate 
prevention 
programs with DS 
as a component 
can reduce suicide 
related events.  
Some 
interventions 
likely not 
generalizable to 
every day 
practice. 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Mojtabai (2010).  
Does depression 
screening have an 
effect on the 
diagnosis and 
treatment of mood 
disorders in 
Practice Variation 
Framework 
Observational 
study / 
quantitative 
 
Purpose: 
examine effects 
of DS on dx and 
n=73,712 
F>M 
RS collected from 
NAMCS 
 
IC: Non -
psychiatric visits 
IV-DS 
DV1- mood 
disorder dx 
DV2- tx with 
antidepressant 
NR Stata 11 
 
Wald tests, Rho 
co-efficients, 
Probit analyses, 
adjusted F tests 
 
DS occurred in 
1.8% of sample 
 
DV1:   
positive 
association 
between DS and 
Level IV 
 
Strengths: 
Large sample 
size, detailed 
explanation of 
methods, 
UNDIAGNOSED DEPRESSION                    24 
Key: AHRQ- Agency for Healthcare Research and Quality; AOR- adjusted odds ratio; ARR- absolute risk reduction; BDI- Beck Depression Inventory; CG- 
Control Group; CI- confidence interval; CIDI- Composite International Diagnosis Interview DS- depression screening; DV-dependent variable; dx- 
diagnosis; EC- exclusion criteria; EHR- electronic health record; f/u- follow-up; GDS- Geriatric Depression Scale; HAM-d- Hamilton Depression Scale; IC- 
inclusion criteria; IV- independent variable; IG- intervention group; IRR- incident rate ratio; MA- meta-analysis; MDD- major depressive disorder; MH- 
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general medical 
settings?  An 
instrumental 
variable analysis 
of the NAMCS. 
 
Funding/Bias/Con
flicts: none 
identified 
 
USA 
tx decisions in 
patients with 
MDD in usual 
practice 
 
 
from 2005-2007 95% CI dx (B=0.690, 
SE=0.087, p< 
0.001) 
Probability of Dx 
in screened 0.039 
vs 0.007 in non-
screened 
 
DV2: 
 positive 
association 
between DS and 
tx (B=0.545, 
SE=0.274, p= < 
0.001) 
Probability of tx 
0.139 in screened 
vs 0.052 in non-
screened 
description of 
conceptual 
framework 
 
Weaknesses: 
 
NAMCS data- 
unable to 
independently 
verify dx, 
screening 
instruments not 
identified 
 
Conclusion: 
 
DS helps identify 
MDD and 
increases 
probability of tx  
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
O’Conner et al. 
(2016). 
Screening for 
depression in 
adults: An 
Population Health 
framework 
SR / quantitative 
 
Purpose: 
Systematically 
review and 
N=71 
n=3,814 
F>M 
 
IC:  
IV1- DS 
IV2- feedback 
IV3- tx 
interventions 
 
PHQ-9; HAM-D; 
Geriatric 
Depression Scale; 
Beck Depression 
Inventory; CES-d 
Stata 13.1 
 
DerSimonian and 
Laird pooled 
estimate; 
DV1 / DV2: 
DS programs 
increased 
remission or tx 
response 20%-
Level I 
 
Strengths: 
 
Sound methods, 
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updated 
systematic 
evidence review 
for the USPSTF. 
 
Funding: AHRQ 
 
Bias/conflicts: 
none identified 
 
USA 
update benefits 
and harms of DS 
in adults to aid 
the USPSTF in 
updating its 
recommendation 
 
Methods: 
Searched 4 
databases from 
2009-2015; 
websites of 
government 
agencies, 
professional 
organizations for 
grey literature; 
reviewed journal 
tables of contents 
Studies targeting 
DS; Brief 
standardized 
instrument 
designed to 
identify persons 
with depression; 
PC settings; 
RCTs, CCTs; SR 
 
EC: 
Comparative 
effectiveness 
studies; study 
populations with 
pre-existing 
depression; 
intervention is 
second line tx; 
studies with f/u 
period < 6 weeks 
 
DV1- depression 
remission 
DV2-symptom 
reduction 
DV3- health 
outcomes 
 
Health outcomes: 
improved 
outcomes defined 
as decreased 
symptoms; 
decreased suicide 
deaths, attempts 
or ideation; 
improved 
functioning; 
improved quality 
of life; improved 
health status 
 
 
Tested for use in 
older adults: 
 
PHQ-9: 
sensitivity 88%, 
specificity 80% 
 GDS: sensitivity 
75%, specificity 
70%, CES-d: 
sensitivity 83%, 
specificity 78%, 
BDI: sensitivity 
88%, specificity 
81.7% 
 
Unknown if tested 
in older adults: 
 
HAM-D 
Egger’s test; 
contingency 
tables; Knapp 
Hartung 
modification; 
Forest plots 
80% 
 
7/9 studies 
showed 
improvement in 
symptoms or 
remission but 
only 2 significant: 
RR 1.19 (95% CI, 
1.06-1.34) 
RR 1.71 (95% CI, 
1.13-2.57) 
NS studies range 
from RR 1.13 
(95% CI, 0.46-
2.79) to RR1.79 
(955 CI, 0.94-
3.41) 
 
 
 
large number of 
studies, thorough 
explanation of 
methods, PC 
setting, adequate 
f/u time among 
studies 
 
Weaknesses: 
 
Many studies 
underpowered to 
detect even large 
differences in 
treatment effect, 
significant 
heterogeneity 
among study 
interventions 
prevents meta-
analysis, greater 
number of 
females 
 
Conclusion: 
 
DS programs are 
effective in 
improving 
symptoms and 
remission when 
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identified MDD 
leads to tx 
 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
O’Conner et al. 
(2009). 
Screening for 
depression in 
adult patients in 
primary care 
settings: A 
systematic 
review. 
 
Funding: AHRQ 
Bias/conflicts: 
none identified 
 
USA 
Population Health 
Framework 
SR / quantitative 
 
Purpose:  
SR for USPSTF 
about benefits 
and harms of 
adult DS in PC 
 
Methods: 
Searched 5 
databases from 
1998-2007 
 
N=33 
n=12,432 
 
IC: 
Study focus on 
DS; outcomes 
identified; SR; 
RCT; large cohort 
studies with 
minimum 1000 
participants; PC 
setting 
 
EC: 
Inpatient setting; 
intervention not 
appropriate for 
PC; focus on 
children; non-
English language; 
IV1-DS 
IV2- DS with 
feedback and/or 
support 
interventions 
IV3-tx 
interventions 
DV1-depressive 
symptoms & 
remission 
DV2-health 
status/outcome 
DV3-depression 
dx 
 
Definitions: 
Health 
status/outcomes 
defined as 
improvement in 
PHQ-9, HAM-D; 
CES-d 
 
Tested for use in 
older adults: 
 
PHQ-9: 
sensitivity 88%, 
specificity 80%, 
CES-d: sensitivity 
83%, specificity 
78% 
 
Unknown if tested 
in older adults: 
 
HAM-D 
SAS 8.2 
 
Poisson 
distribution; 
qualitative 
synthesis 
 
95% CI 
DV1: 
 
IV1- 1 study on 
effects of DS on 
MDD symptoms: 
remission 
achieved in 48% 
screened vs 27% 
of non-screened 
(p < 0.05). 
 
IV2- 
5/7 studies show 
significant 
improvement in 
symptoms and 
remission (p< 
0.05); 
2/7 show NS 
improvement in 
Level I 
 
Strengths: 
Large number of 
studies, examined 
tx in older adults; 
PC setting 
 
Weaknesses: 
Heterogeneity 
among studies 
prevents meta-
analysis, mixed 
quality of studies 
 
Conclusion: 
Findings indicate 
screening 
programs are 
beneficial when 
UNDIAGNOSED DEPRESSION                    27 
Key: AHRQ- Agency for Healthcare Research and Quality; AOR- adjusted odds ratio; ARR- absolute risk reduction; BDI- Beck Depression Inventory; CG- 
Control Group; CI- confidence interval; CIDI- Composite International Diagnosis Interview DS- depression screening; DV-dependent variable; dx- 
diagnosis; EC- exclusion criteria; EHR- electronic health record; f/u- follow-up; GDS- Geriatric Depression Scale; HAM-d- Hamilton Depression Scale; IC- 
inclusion criteria; IV- independent variable; IG- intervention group; IRR- incident rate ratio; MA- meta-analysis; MDD- major depressive disorder; MH- 
mental health; MMSE- mini mental status exam; N-number of studies; n- number of participants; NAMCS-  National Ambulatory Medical Care Survey; 
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outcomes not 
disclosed; f/u 
period < 6 weeks 
comorbid illness, 
reduction in 
physical 
symptoms, 
reduction in SI 
 
Suicidal 
behaviors: acts or 
attempts to self-
harm 
symptoms or 
remission 
 
 
DV2: 
 
IV3- 
suicidal behaviors 
reduced in older 
adults with tx, OR 
0.06 (95% CI, 
0.01-0.58); SI 
reduced in older 
adult OR 0.39 
(95% CI, 0.18-
0.78) 
DS leads to Dx 
and tx; tx reduces 
SI in older adults 
Citation 
 
 
Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Oyama (2016) 
Long-term effects 
of a screening 
intervention for 
depression on 
suicide rates 
among Japanese 
community-
dwelling older 
Inferred- 
Population 
Prevention 
framework 
CCS / 
quantitative 
 
Purpose:  
Evaluate long-
term impact of 
routine 
depression 
screening on 
n= 4,918 
F>M 
Age ≥ 65 
 
Geographic cohort 
sampling 
 
Setting: 
Community 
IV1- DS 
IV2- DS & 
education 
IV3- usual care 
 
DV1-suicide rate 
 
Definitions: 
 
SRDS; GDS; 
CIDI 
 
Validated in older 
adults: 
 
Zung: sensitivity 
58%-76%, 
specificity 82%-
SPSS 
 
Mixed-effects 
binomial 
regression 
models; repeated-
measures linear 
models; IRR 
48% decrease in 
suicide rate in IG 
vs no change in 
CG 
 
IRR in IG 0.52 
(95% CI, 0.33-
0.83, p=0.008) 
 
Level III 
 
Strengths: 
Large sample 
size, long f/u 
period 
 
Weaknesses: 
Japanese study-
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adults 
 
Bias/Conflicts: 
none identified 
 
Funding: 
Japan Ministry of 
Health 
 
Japan 
 
suicide rates in 
older adults 
setting in Japan Usual care: usual 
periodic health 
check-ups for 
general 
population 
 
86% 
GDS: sensitivity 
75%, specificity 
70% 
 
Unknown if 
validated in older 
adults: 
CIDI 
 
IRR in CG 0.93 
(95% CI, 0.69-
1.26) 
 
Ratio of IRR 
between CG and 
IG 1.83 (95% CI, 
1.08-3.09, p= 
0.026) 
may reflect 
cultural factors 
not present in 
U.S. 
 
Conclusion: 
DS programs can 
reduce SI and 
suicide rate  
Citation 
 
 
Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
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Level/Quality of 
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Pfoh et al. (2015). 
Conformance to 
depression 
process measures 
of medicare part b 
beneficiaries in 
primary care 
settings. 
 
Funding: AHRQ 
 
Bias/ Conflicts: 
none identified 
 
Inferred- Quality 
Performance 
Framework 
Cross-sectional 
study using EHR 
data / quantitative 
 
Purpose:  
evaluate 
conformance to 
DS, management, 
and outcome 
quality indicators 
and identify 
characteristics 
associated with 
conformance 
N= 34 clinics 
n= 5000 
F>M 
 
Quota RS: half 
had annual well 
visit and half 
routine visit  
 
IC: selected 
through RS 
 
EC:   
DS within 4 
IV1- annual well 
visit 
IV2- routine visit  
DV-DS 
DV2-
reassessment 
within 3 months 
after new dx of 
MDD 
DV3- depression 
response (> 50% 
reduction in 
symptoms 
measured by 
PHQ-9 
 
Tested in older 
adults: sensitivity 
88%, specificity 
80% 
Stata 12 
 
Descriptive 
analyses; 
Multivariate 
logistic regression 
DS rate 17% 
 
Odds of DS for 
general visit: 
AOR 1.16 (95% 
CI, 0.86-1.55) 
Odds of DS for 
well visit: AOR 
0.41 (95% CI, 
0.30-0.56) 
Odds of 
depression 
response: AOR 
3.93 (95% CI, 
Level IV 
 
Strengths: 
 
Large sample 
size, clear 
findings, PC 
setting, no bias 
noted 
 
Weaknesses: 
 
Lower level 
evidence, 
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USA  to these 
measures. 
 
 
 
 
months; 
depression 
remission within 1 
year 
PHQ-9) 
DV4- remission 
within 12 months 
(PHQ-9 score < 
5) 
1.46-10.57, p < 
0.05) 
 
Odds of 
reassessment 
within 3 months:  
0.71 (95% CI, 
0.17-3.02) 
 
 
retrospective data, 
use of EHR 
records, no 
identification of 
factors that 
contribute to 
increased odds of 
response 
 
Conclusion: 
 
Findings indicate 
rate of DS is low.  
Does show that 
people in study 
with DS had 
greater odds of 
response.   
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables 
& Definitions 
Measurement/Inst
rumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
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Screening for 
depression: 
Systematic 
evidence review. 
 
Funding: AHRQ 
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USA 
 
 
 
 
 
 
 
 
 
Population Health 
Framework 
SR / quantitative 
 
Purpose: 
Examine 
effectiveness of 
DS in PC settings 
 
Methods: 
Searched 2 
databases from 
1966-1999; 
Reviewed 
bibliographies 
N= 70 
n= 15,263 
F>M 
 
IC: 
English language; 
RCT; SR/MA; PC 
setting; original 
research 
 
EC: 
Non-PC setting; 
focus on children; 
non-English; no 
original data 
IV1-DS 
IV2-DS with 
feedback 
 
DV1-dx 
DV2-tx 
DV3-outcomes 
 
Outcome defined 
as decreased 
MDD symptoms, 
improved quality 
of life, and 
reduction in 
morbidity/mortalit
y  
HAM-d; BDI 
 
BDI tested in 
older adults: 
sensitivity 88%, 
specificity 81.7% 
 
 
 
Unknown if 
HAM-d tested in 
older adults 
Stata 6.0 
 
DerSimonian and 
Laird random-
effects model 
Risk of persistent 
MDD after DS:  
RR 0.87 (95% CI, 
0.79-0.95), RRR 
13%; ARR 9%; 
NNT achieve 
remission at 6 
months= 11 
 
DV1: 
4/12 studies 
showed 
significant 
increase in dx (p 
< 0.05) in IG with 
DS vs CG with no 
DS; 
2/12 studies NS 
(p > 0.05); 
6/12 studies did 
not report 
significance data; 
Rate of dx from 
DS increased 
10%-47.5% 
 
DV2: 
4/10 studies had 
higher rates of tx 
in IG vs CG (p < 
0.05); 
Level I 
 
Strengths: 
Large number of 
studies, SR, clear 
methodology, 
clearly stated 
research 
questions, 
detailed 
explanation of 
included studies 
strengths/ 
weaknesses  
 
Weaknesses: 
Level of 
significance NR 
in some studies.  
Heterogeneity of 
studies prevented 
meta-analysis, 
some studies had 
missing data    
 
Conclusion: 
Findings support 
DS in PC.  DS 
increases 
incidence of dx 
and tx.    
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3/10 had higher tx 
in IG vs CG but 
NS; 
2/10 had higher tx 
rates in IG but 
significance NR; 
1/10 studies had 
higher tx rates in 
CG than IG 
 
DV3: 
In 5/9 studies 
significant 
improvement in 
outcomes (p< 
0.05); 
In 1/9 studies 
improvement NS; 
In 3/9 studies, 
outcomes 
improved but 
significance NR 
 
 
 
  
  
 
